Weight LossInvestigational · Research use only
Eloralintide
LY3841136
Investigational, long-acting selective amylin-receptor agonist in clinical development for obesity. Clinical research examines weight management and metabolic outcomes; it is not an approved treatment.
Metabolic
Class
Weight Loss / Metabolic
Targets
Loading research profile
Evidence
1 linked resource
Related
Cagrilintide · Mazdutide
★ Recommended Supplier
Get Eloralintide
Sourced from ION Peptide. Third-party tested. COA available on request.
Buy Eloralintide — 15% OFF15% OFF off with codeSHIA
[01]
Research overview
Benefits
- Amylin-receptor signaling
- Weight-management research
- Investigational metabolic outcomes
Research side effects
- Research-use only; safety data in healthy humans is limited or absent.
- Nausea / GI upset
- Appetite suppression
- Diarrhea or constipation
- GI upset
Timing
Often studied with or before meals; protocols vary by compound.
Common research stacks
Semaglutide
Tirzepatide
RETATRUTIDE
AOD-9604
5-Amino-1MQ
Cagrilintide
[06]
Trusted research partners
Partnered vendors we've verified sell this compound. Links go straight to the product page — use a member code at checkout.
[05]
Studies & resources
Research reference only · Review source material independently · Not medical advice